KEGG: plu:plu2581
STRING: 243265.plu2581
Photorhabdus luminescens subsp. laumondii UPF0283 membrane protein plu2581 (UniProt ID: Q7N3Y1) is a membrane protein from the bacterium Photorhabdus luminescens strain TT01. It belongs to the UPF0283 protein family, which consists of uncharacterized membrane proteins. The full-length protein contains 354 amino acids and appears to have multiple transmembrane domains based on its sequence characteristics .
For optimal stability and activity of recombinant plu2581:
Store the protein at -20°C for regular use
For extended storage, conserve at -20°C or -80°C
Lyophilized protein should be reconstituted in an appropriate buffer
Working aliquots can be stored at 4°C for up to one week
Avoid repeated freeze-thaw cycles as this may compromise protein integrity
The protein is typically supplied in a Tris-based buffer with 50% glycerol
Multiple expression systems are available for producing recombinant plu2581, each with specific advantages:
| Expression System | Advantages | Considerations |
|---|---|---|
| E. coli | High yield, cost-effective, rapid production | May lack post-translational modifications |
| Yeast | Better folding for complex proteins, some post-translational modifications | Longer production time |
| Mammalian cells | Authentic post-translational modifications, proper folding | Most expensive, lower yields |
| Insect cells | High expression levels, post-translational modifications | Moderate cost, specialized equipment needed |
The choice of expression system should be based on the specific research requirements, including the need for post-translational modifications and protein folding considerations .
Various fusion tags can be employed to facilitate expression, purification, and detection of recombinant plu2581:
| Tag Type | Purpose | Position Options |
|---|---|---|
| His Tag | Metal affinity purification | N-terminal or C-terminal |
| FLAG Tag | Immunoaffinity purification, detection | N-terminal or C-terminal |
| MBP | Solubility enhancement, purification | Typically N-terminal |
| GST | Solubility enhancement, purification | Typically N-terminal |
| GFP | Visualization, localization studies | Typically C-terminal |
| Biotin | Interaction studies | N-terminal or C-terminal |
The tag type will be determined during the production process based on specific research needs. For membrane proteins like plu2581, tag position can significantly affect protein folding and functionality .
When designing experiments to study plu2581 membrane localization, consider the following methodological approach:
Fluorescent Tagging Strategy:
Use C-terminal GFP fusion constructs to minimize disruption of membrane insertion
Compare results with N-terminal tagging to identify potential artifacts
Include wild-type controls to assess tag interference
Subcellular Fractionation Protocol:
Employ differential centrifugation to isolate membrane fractions
Verify fractionation quality using known membrane protein markers
Quantify protein distribution using immunoblotting with tag-specific antibodies
Microscopy Validation:
Controls and Validation:
To investigate the potential functions of this uncharacterized membrane protein, implement a structured functional analysis approach:
Comparative Genomics Analysis:
Identify homologs in related species
Examine genomic context for functional associations
Search for conserved domains that might suggest function
Gene Deletion Studies:
Generate knockout mutants using CRISPR-Cas9 or homologous recombination
Perform comprehensive phenotypic characterization
Compare growth rates under various conditions
Protein-Protein Interaction Analysis:
Conduct pull-down assays using tagged recombinant protein
Perform yeast two-hybrid or bacterial two-hybrid screens
Validate interactions using co-immunoprecipitation
Membrane Transport Assays:
When confronting contradictory findings in plu2581 functional studies, implement a systematic contradiction resolution framework:
Parameterized Contradiction Analysis:
Experimental Design Revaluation:
Multi-Method Validation:
Data Integration Strategy:
Phase variation is an important regulatory mechanism in bacteria. When investigating potential phase variation in plu2581 expression, consider the following methodological framework:
Sequence Analysis for Phase Variation Mechanisms:
Single-Cell Expression Analysis:
Genetic Stability Assessment:
Transcription Termination Analysis:
When investigating the potential involvement of plu2581 in bacterial-host interactions, employ the following methodological approach:
Expression Pattern Analysis:
Monitor plu2581 expression levels during different phases of host interaction
Compare expression between free-living and host-associated bacterial populations
Identify host factors that might trigger expression changes
Mutant Phenotype Characterization:
Generate plu2581 deletion and overexpression mutants
Assess mutant ability to colonize hosts compared to wild-type
Measure bacterial persistence in different host tissues
Host Response Analysis:
Compare host immune responses to wild-type and plu2581 mutant bacteria
Measure inflammatory markers and immune cell recruitment
Assess potential epithelial barrier disruption
Protein Localization During Infection:
To ensure high-quality recombinant plu2581 for research applications, implement the following quality control measures:
| Parameter | Method | Acceptance Criteria |
|---|---|---|
| Purity | SDS-PAGE | >80-95% depending on application |
| Identity | Mass spectrometry | Match to theoretical mass |
| Tag presence | Western blot | Positive signal with tag-specific antibody |
| Secondary structure | Circular dichroism | Consistent with membrane protein profile |
| Aggregation state | Size exclusion chromatography | Minimal aggregation |
| Endotoxin level | LAL assay | <1 EU/mg for cell-based assays |
| Batch-to-batch variation | Functional assays | <15% variation between batches |
For membrane proteins like plu2581, additional tests for proper folding and membrane insertion may be necessary to ensure biological relevance of experimental results .
When working with membrane proteins like plu2581, researchers should anticipate and address these common challenges:
Solubility and Aggregation Issues:
Optimize detergent type and concentration for extraction
Consider using amphipols or nanodiscs for stabilization
Test different buffer compositions to improve solubility
Expression Level Optimization:
Adjust induction conditions (temperature, inducer concentration)
Test different promoter strengths
Consider specialized expression strains for membrane proteins
Purification Challenges:
Implement two-step purification strategies
Optimize detergent exchange during purification
Use size exclusion chromatography as a final polishing step
Functional Assay Development: